These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23482237)

  • 1. Pharmacodynamics of florfenicol for calf pneumonia pathogens.
    Illambas J; Potter T; Sidhu P; Rycroft AN; Cheng Z; Lees P
    Vet Rec; 2013 Mar; 172(13):340. PubMed ID: 23482237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
    Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
    Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Potter T; Pelligand L; Toutain PL
    J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
    Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
    Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Pelligand L; Toutain PL
    Vet J; 2016 Dec; 218():60-64. PubMed ID: 27938710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves.
    Sidhu P; Rassouli A; Illambas J; Potter T; Pelligand L; Rycroft A; Lees P
    J Vet Pharmacol Ther; 2014 Jun; 37(3):231-42. PubMed ID: 24341543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of oxytetracycline administered alone and in combination with carprofen in calves.
    Brentnall C; Cheng Z; McKellar QA; Lees P
    Vet Rec; 2012 Sep; 171(11):273. PubMed ID: 22843613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
    McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
    J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Potter TJ; Pelligand L; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2017 Oct; 40(5):419-428. PubMed ID: 27891615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    PLoS One; 2017; 12(5):e0177568. PubMed ID: 28552968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
    Sweeney MT; Brumbaugh GW; Watts JL
    Vet Ther; 2008; 9(3):212-22. PubMed ID: 19003782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
    Portis E; Lindeman C; Johansen L; Stoltman G
    J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance of bovine and porcine Pasteurella to florfenicol and other antibiotics].
    Hörmansdorfer S; Bauer J
    Berl Munch Tierarztl Wochenschr; 1998; 111(11-12):422-6. PubMed ID: 9880937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle.
    Schwarz S; Kehrenberg C; Salmon SA; Watts JL
    J Antimicrob Chemother; 2004 Feb; 53(2):379-82. PubMed ID: 14729757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of florfenicol for Actinobacillus pleuropneumoniae and Pasteurella multocida using standardised versus non-standardised methodology.
    Dorey L; Hobson S; Lees P
    Vet J; 2016 Dec; 218():65-70. PubMed ID: 27938711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal effects of various concentrations of enrofloxacin, florfenicol, tilmicosin phosphate, and tulathromycin on clinical isolates of Mannheimia haemolytica.
    Blondeau JM; Shebelski SD; Hesje CK
    Am J Vet Res; 2015 Oct; 76(10):860-8. PubMed ID: 26413823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
    Sweeney MT; Papich MG; Watts JL
    J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential susceptibility to tetracycline, oxytetracycline and doxycycline of the calf pathogens Mannheimia haemolytica and Pasteurella multocida in three growth media.
    Mead A; Lees P; Mitchell J; Rycroft A; Standing JF; Toutain PL; Pelligand L
    J Vet Pharmacol Ther; 2019 Jan; 42(1):52-59. PubMed ID: 30267412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
    Dorey L; Lees P
    BMC Vet Res; 2017 Jun; 13(1):192. PubMed ID: 28645327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.